-
1
-
-
0033398454
-
Immune defects observed in patients with primary malignant brain tumors
-
Dix, A.R.; Brooks, W.H.; Roszman, T.L.; Morford, L.A.; Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol; 1999, 100, 216-232.
-
(1999)
J. Neuroimmunol.
, vol.100
, pp. 216-232
-
-
Dix, A.R.1
Brooks, W.H.2
Roszman, T.L.3
Morford, L.A.4
-
2
-
-
0024399070
-
Immunosuppression and transforming growth factor-beta in glioblastoma. Referential production of transforming growth factor-beta 2
-
Bodmer, S.; Strommer, K.; Frei, K.; Siepl, C.; de Tribolet, N.; Heid, I.; et al. Immunosuppression and transforming growth factor-beta in glioblastoma. referential production of transforming growth factor-beta 2. J. Immunol. 1989, 43, 3222-3229.
-
(1989)
J. Immunol.
, vol.43
, pp. 3222-3229
-
-
Bodmer, S.1
Strommer, K.2
Frei, K.3
Siepl, C.4
De Tribolet, N.5
Heid, I.6
-
3
-
-
0025741809
-
Human glioblastoma cell derived transforming growth factor-beta 2: Evidence for secretion of both high and low molecular weight biologically active forms
-
Bodmer, S.; Huber, D.; Heid, I.; Fontana, A. Human glioblastoma cell derived transforming growth factor-beta 2: Evidence for secretion of both high and low molecular weight biologically active forms. J Neuroimmunol. 1991, 34, 33-42.
-
(1991)
J. Neuroimmunol.
, vol.34
, pp. 33-42
-
-
Bodmer, S.1
Huber, D.2
Heid, I.3
Fontana, A.4
-
4
-
-
0023477137
-
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family
-
De Martin, R.; Haendler, B.; Hofer-Warbinek, R.; Gaugitsch, H.; Wrann Schlusener, H.; Seifert, J.M.; et al. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J. 1987, 6, 3673-3677.
-
(1987)
EMBO J.
, vol.6
, pp. 3673-3677
-
-
De Martin, R.1
Haendler, B.2
Hofer-Warbinek, R.3
Gaugitsch, H.4
Wrann Schlusener, H.5
Seifert, J.M.6
-
5
-
-
0021344432
-
Glioblastoma cells release Interleukin 1 and factors inhibiting interleukin2-mediated effects
-
Fontana, A.; Hengartner, H.; de Tribolet, N.; Weber, E. Glioblastoma cells release Interleukin 1 and factors inhibiting interleukin2-mediated effects. J Immunol. 1984, 132, 1837-1844.
-
(1984)
J. Immunol.
, vol.132
, pp. 1837-1844
-
-
Fontana, A.1
Hengartner, H.2
De Tribolet, N.3
Weber, E.4
-
6
-
-
0024392891
-
Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2
-
Kuppner, M.C.; Hamou, M.F.; Sawamura, Y.; Bodmer, S.; de Tribolet, N.; Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2. J. Neurosurg. 1989, 71, 211-217.
-
(1989)
J. Neurosurg.
, vol.71
, pp. 211-217
-
-
Kuppner, M.C.1
Hamou, M.F.2
Sawamura, Y.3
Bodmer, S.4
De Tribolet, N.5
-
7
-
-
0023936408
-
The glioblastoma-derived, T cell suppressor factor transforming growth factor-beta 2 inhibits, T.; cell growth without affecting the interaction of interleukin 2 with its receptor
-
Siepl, C.; Bodmer, S.; Frei, K.; MacDonald, H.R.; De Martin, R.; Hofer, E.; et al. The glioblastoma-derived, T cell suppressor factor transforming growth factor-beta 2 inhibits, T.; cell growth without affecting the interaction of interleukin 2 with its receptor. Eur J. Immunol. 1988, 18, 593-600.
-
(1988)
Eur. J. Immunol.
, vol.18
, pp. 593-600
-
-
Siepl, C.1
Bodmer, S.2
Frei, K.3
MacDonald, H.R.4
De Martin, R.5
Hofer, E.6
-
8
-
-
0023354032
-
T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta
-
Wrann, M.; Bodmer, S.; de Martin, R.; Siepl, C.; Hofer-Warbinek, R.; Frei, K.; et al. T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J. 1987, 6, 1633-1636.
-
(1987)
EMBO J.
, vol.6
, pp. 1633-1636
-
-
Wrann, M.1
Bodmer, S.2
De Martin, R.3
Siepl, C.4
Hofer-Warbinek, R.5
Frei, K.6
-
9
-
-
0024514296
-
Prostaglandin and thromboxane synthesis by human intracranial tumors
-
Castelli, M.G.; Chiabrando, C.; Fanelli, R.; Martelli, L.; Butti, G.; Gaetani, P.; et al. Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res. 1989, 49, 1505-1508.
-
(1989)
Cancer Res.
, vol.49
, pp. 1505-1508
-
-
Castelli, M.G.1
Chiabrando, C.2
Fanelli, R.3
Martelli, L.4
Butti, G.5
Gaetani, P.6
-
10
-
-
0025773050
-
Malignant glioma modulation of immune function: Relative contribution of different soluble factors
-
Couldwell, W.T.; DoreDuffy, P.; Apuzzo, M.L.; Antel, J.P. Malignant glioma modulation of immune function: Relative contribution of different soluble factors. J Neuroimmunol. 1991, 33, 89-96.
-
(1991)
J. Neuroimmunol.
, vol.33
, pp. 89-96
-
-
Couldwell, W.T.1
Doreduffy, P.2
Apuzzo, M.L.3
Antel, J.P.4
-
11
-
-
0027248910
-
Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10
-
Bogdan, C.; Nathan, C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 1993, 685, 713-739.
-
(1993)
Ann. NY Acad. Sci.
, vol.685
, pp. 713-739
-
-
Bogdan, C.1
Nathan, C.2
-
12
-
-
0026607155
-
IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function
-
Ding, L.; Shevach, E.M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol. 1992, 148, 3133-3139.
-
(1992)
J. Immunol.
, vol.148
, pp. 3133-3139
-
-
Ding, L.1
Shevach, E.M.2
-
13
-
-
0025763807
-
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
-
Fiorentino, D.F.; Zlotnik, A.; Vieira, P.; Mosmann, T.R.; Howard, M.; Moore, K.W. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991, 46, 3444-3451.
-
(1991)
J. Immunol.
, vol.46
, pp. 3444-3451
-
-
Fiorentino, D.F.1
Zlotnik, A.2
Vieira, P.3
Mosmann, T.R.4
Howard, M.5
Moore, K.W.6
-
14
-
-
0026570853
-
IL-10 inhibit human T cell proliferation and IL-2 production
-
Taga, K.; Tosato, G. IL-10 inhibit human T cell proliferation and IL-2 production. J. Immunol. 1992, 148, 1143-1148.
-
(1992)
J. Immunol.
, vol.148
, pp. 1143-1148
-
-
Taga, K.1
Tosato, G.2
-
15
-
-
0021712675
-
Inhibition of interleukin-2-dependent cytotoxic T-lymphocyte growth by gangliosides
-
Merritt, W.D.; Bailey, J.M.; Pluznik, D.H.; Inhibition of interleukin-2-dependent cytotoxic T-lymphocyte growth by gangliosides. Cell Immunol. 1984, 89, 1-10.
-
(1984)
Cell Immunol.
, vol.89
, pp. 1-10
-
-
Merritt, W.D.1
Bailey, J.M.2
Pluznik, D.H.3
-
16
-
-
0023635493
-
Gangliosides induce selective modulation of CD4 from helper, T.; lymphocytes
-
Offner, H.; Thieme, T.; Vandenbark, A.A. Gangliosides induce selective modulation of CD4 from helper, T.; lymphocytes, J. Immunol. 1987, 139, 3295-3305.
-
(1987)
J. Immunol.
, vol.139
, pp. 3295-3305
-
-
Offner, H.1
Thieme, T.2
Vandenbark, A.A.3
-
17
-
-
33750060634
-
-
Nidus Information Services, Inc., 41 East 11th Street, 11th Floor, New York, NY 10003 or email office@well-connected.com or on the internet at
-
Nidus Information Services, Inc., 41 East 11th Street, 11th Floor, New York, NY 10003 or email office@well-connected.com or on the internet at www.well-connected.com.
-
-
-
-
19
-
-
0035892135
-
Activation of apoptosis pathways in peripheral blood lymphocytes in in vivo chemotherapy
-
Stahnke, K.; Simone, F.; Friesen, C.; Straub, G.; Debatin, K.M.; Activation of apoptosis pathways in peripheral blood lymphocytes in in vivo chemotherapy. Neoplasia. 2001, 98 (10), 3066-3073.
-
(2001)
Neoplasia
, vol.98
, Issue.10
, pp. 3066-3073
-
-
Stahnke, K.1
Simone, F.2
Friesen, C.3
Straub, G.4
Debatin, K.M.5
-
20
-
-
0033030318
-
Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy
-
Louagie, H.; Van Eijkeren, M.; Philippe, L.; Thierens, H.; Ridder de, L. Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy. Int. J. of Radiation. Biol. 1999, 75, (6), 767-771.
-
(1999)
Int. J. of Radiation. Biol.
, vol.75
, Issue.6
, pp. 767-771
-
-
Louagie, H.1
Van Eijkeren, M.2
Philippe, L.3
Thierens, H.4
Ridder De, L.5
-
21
-
-
0028276997
-
Effects of radiation on survival and recovery of T lymphocyte subsetw in C3H/HeN mice
-
Willams, J.L.; Patchen, M.L.; Darden, J.H.; Jackson, W.E.; Effects of radiation on survival and recovery of T lymphocyte subsetw in C3H/HeN mice. Exp. Hematol. 1994, 22 (6), 510-516.
-
(1994)
Exp. Hematol.
, vol.22
, Issue.6
, pp. 510-516
-
-
Willams, J.L.1
Patchen, M.L.2
Darden, J.H.3
Jackson, W.E.4
-
23
-
-
2342608152
-
-
Central Drugs standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare, Govt. of India, New Delhi. Drug Controller General, India
-
Good clinical Practice, Central Drugs standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare, Govt. of India, New Delhi. Drug Controller General, India.
-
Good Clinical Practice
-
-
-
24
-
-
1942452929
-
Immunotherapeutic effects of T11TS/SLFA-3 against nitrosocompound mediated neural genotoxicity
-
Mukherjee, J.; Sarkar, S.; Ghosh, A.; Duttagupta, A.K.; Chaudhuri, S.; Chaudhuri Swapna. Immunotherapeutic effects of T11TS/SLFA-3 against nitrosocompound mediated neural genotoxicity. Tox. Lett. 2004, 150, (3): 239-257.
-
(2004)
Tox. Lett.
, vol.150
, Issue.3
, pp. 239-257
-
-
Mukherjee, J.1
Sarkar, S.2
Ghosh, A.3
Duttagupta, A.K.4
Chaudhuri, S.5
Swapna, C.6
-
25
-
-
9744224555
-
Preclinical changes in immunoreactivity and cellular architecture during the progressive development of intracranial neoplasm and its immunotherapeutic schedule with a novel biological response modifier, the T11TS/SLFA-3
-
Mukherjee, J.; Sarkar, S.; Begurn, Z.; Dutta, S.; Ghosh, A.; Chaudhuri, S.; Chaudhuri, Swapna. Preclinical changes in immunoreactivity and cellular architecture during the progressive development of intracranial neoplasm and its immunotherapeutic schedule with a novel biological response modifier, the T11TS/SLFA-3. Asian Pacific J. Cancer Prevention. 2002, 3, 325-337.
-
(2002)
Asian Pacific J. Cancer Prevention
, vol.3
, pp. 325-337
-
-
Mukherjee, J.1
Sarkar, S.2
Begurn, Z.3
Dutta, S.4
Ghosh, A.5
Chaudhuri, S.6
Chaudhuri, S.7
-
26
-
-
0036223235
-
Sheep form of Leucocyte Function Antigen-3 (T IITS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor: A new approach to biological response modifier therapy
-
Sarkar, S.; Begum, Z.; Dutta, S.; Chaudhuri, S.; Chaudhuri Swapna. Sheep form of Leucocyte Function Antigen-3 (T IITS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor: A new approach to biological response modifier therapy. J. Exp. Clin. Cancer Res. 2002, 21(1), 95-106.
-
(2002)
J. Exp. Clin. Cancer Res.
, vol.21
, Issue.1
, pp. 95-106
-
-
Sarkar, S.1
Begum, Z.2
Dutta, S.3
Chaudhuri, S.4
Swapna, C.5
-
27
-
-
0028074499
-
Lymphocyte depletion during treatment with intensive chemotherapy for cancer
-
Mackall, C.-L.; Fleisher, T.-A.; Brown, M.-R.; et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood. 1994, 84, 2221-2228.
-
(1994)
Blood
, vol.84
, pp. 2221-2228
-
-
Mackall, C.-L.1
Fleisher, T.-A.2
Brown, M.-R.3
-
28
-
-
18744435046
-
Restoration of T cell homeostasis after T cell depletion
-
Mackall, C.-L., Hakim, F.-T., Gress, R.-E. Restoration of T cell homeostasis after T cell depletion. Semin Immunol. 1997, 9, 339-346.
-
(1997)
Semin. Immunol.
, vol.9
, pp. 339-346
-
-
Mackall, C.-L.1
Hakim, F.-T.2
Gress, R.-E.3
-
29
-
-
0015461544
-
Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor
-
Brooks, W.H.; Netsky, M.G.; Normansell, D.E.; Horwitz, D.A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J. Exp. Med. 1972, 136, 1631-1647.
-
(1972)
J. Exp. Med.
, vol.136
, pp. 1631-1647
-
-
Brooks, W.H.1
Netsky, M.G.2
Normansell, D.E.3
Horwitz, D.A.4
-
30
-
-
0023853364
-
Ialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas
-
Mahaley, M.S. Jr.; Brooks, W.H.; Roszman, T.L.; Bigner, D.D.; Dudka, L. Ialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas. J. Neurochem. 1988, 50, 912-919.
-
(1988)
J. Neurochem.
, vol.50
, pp. 912-919
-
-
Mahaley Jr., M.S.1
Brooks, W.H.2
Roszman, T.L.3
Bigner, D.D.4
Dudka, L.5
-
31
-
-
0017092669
-
Cellular immune deficiency in patients with glioblastoma
-
Young, H.F.; Kaplan, A.M. Cellular immune deficiency in patients with glioblastoma. Surg. Forum. 1976, 27, 476-478.
-
(1976)
Surg. Forum.
, vol.27
, pp. 476-478
-
-
Young, H.F.1
Kaplan, A.M.2
-
32
-
-
0017654660
-
Immunobiology of primary intracranial tumours: II. Analysis of lymphocyte subpopulations in patients with primary brain tumours
-
Brooks, W.H.; Roszman, T.L.; Mahaley, M.S.; Woosley, R.E. Immunobiology of primary intracranial tumours: II. Analysis of lymphocyte subpopulations in patients with primary brain tumours. Clin. Exp. Immunol. 1977, 29, 61-66.
-
(1977)
Clin. Exp. Immunol.
, vol.29
, pp. 61-66
-
-
Brooks, W.H.1
Roszman, T.L.2
Mahaley, M.S.3
Woosley, R.E.4
-
33
-
-
0027056895
-
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
-
Mizoguchi, H.; O'Shea, J.J.; Longo, D.L.; Loeffler, C.M.; McVicar, D.W.; Ochoa, A.C. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992, 258, 1795-1798.
-
(1992)
Science
, vol.258
, pp. 1795-1798
-
-
Mizoguchi, H.1
O'Shea, J.J.2
Longo, D.L.3
Loeffler, C.M.4
McVicar, D.W.5
Ochoa, A.C.6
-
34
-
-
0030610033
-
Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors
-
Gratas, C.; Tohma, Y.; Van Meir, E.G.; Klein, M.; Tenan, M.; Ishii, N.; Tachibana, O.; Kleihues, P.; Ohgaki, H. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol. 1997, 7, 863-869.
-
(1997)
Brain Pathol.
, vol.7
, pp. 863-869
-
-
Gratas, C.1
Tohma, Y.2
Van Meir, E.G.3
Klein, M.4
Tenan, M.5
Ishii, N.6
Tachibana, O.7
Kleihues, P.8
Ohgaki, H.9
-
35
-
-
0030895084
-
Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
-
Saas, P.; Walker, P.R.; Hahne, M.; Quiquerez, A.L.; Schnuriger, V.; Perrin, G. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 1997, 99, 1173-1178.
-
(1997)
J. Clin. Invest.
, vol.99
, pp. 1173-1178
-
-
Saas, P.1
Walker, P.R.2
Hahne, M.3
Quiquerez, A.L.4
Schnuriger, V.5
Perrin, G.6
-
36
-
-
0030883910
-
CD95-dependent, T cell killing by glioma Cells expressing CD95 ligand: More on tumor immune escape, the CD95 counterattack, and the immune privilege of the brain
-
Weller, M.; Weinstock, C.; Will, C.; Wagenknecht, B.; Dichgans, J.; Lang, F.; Gulbins, E. CD95-dependent, T cell killing by glioma Cells expressing CD95 ligand: more on tumor immune escape, the CD95 counterattack, and the immune privilege of the brain. Cell Physiol. Biochem. 1997, 7, 282-288.
-
(1997)
Cell Physiol. Biochem.
, vol.7
, pp. 282-288
-
-
Weller, M.1
Weinstock, C.2
Will, C.3
Wagenknecht, B.4
Dichgans, J.5
Lang, F.6
Gulbins, E.7
-
37
-
-
0031923778
-
CD95 ligand: Lethal weapon against malignant glioma
-
Weller, M.; Kleihus, P.; Dichgans, J.; Ohgaki, H. CD95 ligand: Lethal weapon against malignant glioma. Brain Pathology. 1998, 8, 285-293.
-
(1998)
Brain Pathology
, vol.8
, pp. 285-293
-
-
Weller, M.1
Kleihus, P.2
Dichgans, J.3
Ohgaki, H.4
-
38
-
-
0028840285
-
Induction of acute phase gene expression by brain irradiation
-
Hong, J.H.; Chiang, C.S.; Campbell, I.L.; Sun, J.R.; Withers, H.R.; McBride, W.H. Induction of acute phase gene expression by brain irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33, 619-626.
-
(1995)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.33
, pp. 619-626
-
-
Hong, J.H.1
Chiang, C.S.2
Campbell, I.L.3
Sun, J.R.4
Withers, H.R.5
McBride, W.H.6
-
39
-
-
0036070643
-
Radiotherapy and chemotherapy-induced normal tissue damage: The role of cytokines and adhesion molecules
-
Plevova, P. Radiotherapy and chemotherapy-induced normal tissue damage: the role of cytokines and adhesion molecules. Radiol. Oncol. 2002 36 (2), 109-119.
-
(2002)
Radiol. Oncol.
, vol.36
, Issue.2
, pp. 109-119
-
-
Plevova, P.1
-
40
-
-
0029828032
-
Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: Influence of conditioning and hematopoietic reconstitution
-
Schwaighofer, H.; Kernan, N.A.; O'Reilly, R.J.; Brankova, J.; Nachbaur, D.; Herold, M.; et al. Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution. Transplantation. 1996, 62, 947-953.
-
(1996)
Transplantation
, vol.62
, pp. 947-953
-
-
Schwaighofer, H.1
Kernan, N.A.2
O'Reilly, R.J.3
Brankova, J.4
Nachbaur, D.5
Herold, M.6
-
41
-
-
0242490157
-
Second cancers after radiotherapy: Any evidence for radiation induced genomic instability
-
Sigurdson, J.A.; Jones, I.M. Second cancers after radiotherapy: any evidence for radiation induced genomic instability. Oncogene. 2003, 22, 7018-7027.
-
(2003)
Oncogene
, vol.22
, pp. 7018-7027
-
-
Sigurdson, J.A.1
Jones, I.M.2
-
42
-
-
0035963326
-
Cells and tumors
-
Pardoll, D.T. cells and tumors. Nature 411, 1010-1012.
-
Nature
, vol.411
, pp. 1010-1012
-
-
Pardoll, D.T.1
-
43
-
-
0023272065
-
Rosetting of activated human, T.; lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function associated antigen 3 (LFA-3)
-
Plunkett, M.L.; Sanders, M.E.; Selvaraj, P.; et al. Rosetting of activated human, T.; lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function associated antigen 3 (LFA-3). J. Exp. Med. 1987, 165, 664-676.
-
(1987)
J. Exp. Med.
, vol.165
, pp. 664-676
-
-
Plunkett, M.L.1
Sanders, M.E.2
Selvaraj, P.3
-
44
-
-
0025088396
-
Antitumor activity of Lasparaginase from Cylindrocarpon obstutisporum MB10 and its effect on the immune system
-
Raha, S.K.; Dey, S.K.; Roy, S.K. Antitumor activity of Lasparaginase from Cylindrocarpon obstutisporum MB10 and its effect on the immune system. Biochem. Int. 1990 21, 987-1000.
-
(1990)
Biochem. Int.
, vol.21
, pp. 987-1000
-
-
Raha, S.K.1
Dey, S.K.2
Roy, S.K.3
|